Glucocorticoid Programming in Very Preterm Birth

Area of Science:

• Neonatal Medicine
• Endocrinology
• Developmental Biology

Background:

• Very preterm infants (<32 weeks gestation) exhibit compromised responses to physiological stress due to adrenocortical insufficiency.
• Postnatally, these infants may develop features of increased glucocorticoid bioactivity later in life.
• Sustained elevation in hypothalamus-pituitary-adrenal axis activity post-birth is hypothesized to link prematurity with long-term health risks.

Purpose of the Study:

• To review studies on adrenocortical function in very preterm newborns.
• To examine the age-related changes in the hypothalamus-pituitary-adrenal axis in this population.
• To explore the potential mechanisms linking early adrenocortical function to long-term outcomes.

Main Methods:

• Literature review of studies investigating adrenocortical function in very preterm infants.
• Analysis of studies examining the developmental trajectory of the hypothalamus-pituitary-adrenal axis.
• Synthesis of evidence on the association between prematurity, adrenocortical activity, and later-life health.

Main Results:

• Very preterm infants show initial adrenocortical insufficiency.
• Evidence suggests a persistent elevation in hypothalamus-pituitary-adrenal axis activity beyond infancy.
• These alterations are associated with adverse effects on growth, body composition, metabolism, and neurodevelopment.

Conclusions:

• Adrenocortical function and hypothalamus-pituitary-adrenal axis regulation in very preterm infants are critical factors influencing long-term health.
• Understanding these changes may elucidate the mechanisms behind increased chronic disease risk in this population.
• Further research is needed to fully elucidate the mechanisms and inform interventions.